The genetic background of Parkinson's disease: current progress and future prospects.
about
Ubc13: the Lys63 ubiquitin chain building machineStructure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson's Disease.Genetic Mutation Analysis of Parkinson's Disease Patients Using Multigene Next-Generation Sequencing Panels.Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson's disease etiology.Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population.Modeling neurological diseases with induced pluripotent cells reprogrammed from immortalized lymphoblastoid cell lines.Mutation Analysis of HTRA2 Gene in Chinese Familial Essential Tremor and Familial Parkinson's Disease.The vicious circle of hypometabolism in neurodegenerative diseases: Ways and mechanisms of metabolic correction.TMEM230 in Parkinson's disease.From Reproducibility to Translation in Neurodegenerative Disease.Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.Genetic Analysis of FBXO2, FBXO6, FBXO12, and FBXO41 Variants in Han Chinese Patients with Sporadic Parkinson's Disease.Rabs, Membrane Dynamics, and Parkinson's Disease.Non-human primate models of PD to test novel therapies.Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.The Role of BiP Retrieval by the KDEL Receptor in the Early Secretory Pathway and its Effect on Protein Quality Control and Neurodegeneration.Whole-exome sequencing associates novel CSMD1 gene mutations with familial Parkinson diseaseArm swing as a potential new prodromal marker of Parkinson's disease.Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson's disease phenotypes.The role of gene variants in the pathogenesis of neurodegenerative disorders as revealed by next generation sequencing studies: a review.Parkinson disease polygenic risk score is associated with Parkinson disease status and age at onset but not with alpha-synuclein cerebrospinal fluid levels.Computational systems biology approaches for Parkinson's disease.The need to develop a patient-centered precision medicine model for adults with chronic disability.A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations.Neurotoxins as Preclinical Models for Parkinson's Disease.Variable PARK2 Mutations Cause Early-Onset Parkinson's Disease in a Small Restricted Population.Calcium Channel Antagonists as Disease-Modifying Therapy for Parkinson's Disease: Therapeutic Rationale and Current Status.The M458L missense mutation disrupts the catalytic properties of Parkin.Bimolecular Fluorescence Complementation of Alpha-synuclein Demonstrates its Oligomerization with Dopaminergic Phenotype in Mice.Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations.Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process.Multi-Target Protective Effects of Gintonin in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Mediated Model of Parkinson's Disease via Lysophosphatidic Acid Receptors.Localized delivery of curcumin into brain with polysorbate 80-modified cerasomes by ultrasound-targeted microbubble destruction for improved Parkinson's disease therapy.Gene Therapy for Parkinson's Disease, An Update.Multitarget effects of Korean Red Ginseng in animal model of Parkinson's disease: antiapoptosis, antioxidant, antiinflammation, and maintenance of blood-brain barrier integrity.Prevention of progression in Parkinson's diseaseEpigenetic Study in Parkinson's Disease: A Pilot Analysis of DNA Methylation in Candidate Genes in BrainApplication of Precision Medicine in Neurodegenerative Diseases
P2860
Q26739716-7A5A5BD9-21D1-46F7-B7F9-6D2EC5E82E12Q33701172-40414A72-24E5-4DE0-B884-919D12A75312Q36050210-B7D08699-91FE-4646-AF2C-1EDBADA8ABCDQ37129119-A5EF9D73-B6DD-4F6F-B631-997984D1D7B1Q37271108-86312FF4-A0DA-4BE7-AEA0-5178CAD2F91CQ37304493-725C6E70-B7CB-49AE-AD05-ADFA8BE33EADQ37627534-12CB26EA-DD3B-484F-A413-73D79AFA0CC4Q38809233-D92C3D94-66F3-4D17-92E5-BBA1AAA65D9BQ38812225-85D1158E-0829-4003-95BA-9F3707081962Q38819341-7B48B319-1D9B-4505-8570-86BAB6504FEAQ38838536-717A1448-06F4-4978-911B-B44643E41EC6Q38877162-40586806-FE28-4515-8FC8-9C1E55F187AEQ39031304-95C9984B-2680-47E7-B27F-C4AB6FC3731DQ39229450-6E4239A4-93FE-47B0-B7C7-5A167B3C03ECQ39230378-5A95A2F6-FCAA-4C3F-80E9-13AA23C2E71DQ40059220-2E8137C7-506E-467C-9EFC-649DCF9B4663Q41023936-0220A1A4-D1C6-49E4-8EA8-9DD325D36571Q41217598-C4D4A723-AD9B-4157-A12E-60D89FA97AAFQ41355527-E7716D0A-286F-4427-AEDC-BE57F9D86019Q42120365-4E34BAAB-4CB1-44A8-8FE3-47C6772B6A17Q42376536-1CB7F8CB-CA29-4604-AD10-52A200379BB1Q45915163-C64C7AD7-43BC-4255-ADB2-BE25EA1E9060Q45943481-C1FB1782-E046-4CA9-8962-B92F82B35EFFQ45999025-AF959C9B-FE43-43A2-AC44-7C921C849245Q47871666-092E5841-8F24-4875-B24E-27F57554B0AEQ48291354-5F1EA01A-1660-4B66-A556-8EE707D91CFFQ48341795-AB30B16F-8631-420A-BC3E-AB9984C36681Q48435757-0FDD319C-86C3-4AAC-B2DA-84A4EA6F9E6BQ49981917-2BEBA4AA-6BCE-4F37-B171-3E6EF0D92710Q50056490-425F7D9B-E197-4B3A-AEE1-51D153B35881Q51735537-246684FB-3F64-4F59-8140-FA2019DAB919Q52559939-4661618E-AB9E-4199-BB52-98B446BD8674Q55209327-D9FD1E72-5874-4069-B4F1-641CAD61F7C3Q55231878-2243FFE4-21C2-46EF-8EE0-4FC45A91CE84Q55418920-0B546FA1-A45F-4BB1-B8ED-3B9E623617B5Q55516173-EDBA1D20-474E-4EFE-BE98-B07B59B6229EQ58486541-141A32D3-DB94-4690-BDF8-CC9BB241907CQ58693508-03C0AB7B-D7CA-4380-9982-1A5AE498C565Q58712882-4298E50C-9379-4B95-B28C-13854FB22BFC
P2860
The genetic background of Parkinson's disease: current progress and future prospects.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The genetic background of Parkinson's disease: current progress and future prospects.
@ast
The genetic background of Parkinson's disease: current progress and future prospects.
@en
The genetic background of Parkinson's disease: current progress and future prospects.
@nl
type
label
The genetic background of Parkinson's disease: current progress and future prospects.
@ast
The genetic background of Parkinson's disease: current progress and future prospects.
@en
The genetic background of Parkinson's disease: current progress and future prospects.
@nl
prefLabel
The genetic background of Parkinson's disease: current progress and future prospects.
@ast
The genetic background of Parkinson's disease: current progress and future prospects.
@en
The genetic background of Parkinson's disease: current progress and future prospects.
@nl
P2093
P2860
P356
P1476
The genetic background of Parkinson's disease: current progress and future prospects.
@en
P2093
K Kalinderi
S Bostantjopoulou
P2860
P304
P356
10.1111/ANE.12563
P407
P577
2016-02-12T00:00:00Z